Skip to main content
. 2020 Sep 1;25(17):3982. doi: 10.3390/molecules25173982

Figure 19.

Figure 19

The structures of PCDs used for conjugation with different anti-HIV agents: (a) G1-S4, (b) G2-S16, (c) G3-S16. Adapted from [206], published by J. Nanobiotechnol. 2019.